All Type of News
Bayer urged to restart compassionate use program of Kogenate
A local hemophiliac group has called for Bayer to re-initiate their compassionate use program of Kogenate FS, antihemophilic factor (recombinant) for 21 Korean patients.
Kogenate is a recombinant factor VIII treatm...
Dong-A wins Taxotele patent suit against Sanofi-Aventis
French drug maker Sanofi-Aventis SA lost a patent lawsuit against Dong-A Pharmaceutical over its treatment for colorectal cancer, Taxotele (docetaxel) that is marketed in more than 100 countries to treat lung, prostat...
Zuellig Pharma to distribute L’oreal products to pharmacy
Zuellig Pharma Korea said recently it has signed an agreement with L’oreal Korea to supply the latter’s three flagship products to pharmacy market – hair dye, UV-screening agent and lipcare.
“We will provide pharma...
Drug pricing reform corners Korean drugmakers
A new wave of price cuts for drugs is speculated to be imminent, which has stirred up concerns among drug makers, domestic and multinational alike.
Domestic drug makers are concerned by the potentially significant ...
KFDA to reclassify 17 prescription drugs as OTCs
The Korea Food and Drug Administration plans to reclassify 17 prescription drugs as over-the-counter (OTC) drugs that can be purchased at pharmacy without a doctor’s prescription.
The KFDA officials said that the m...
Drug Utilization Review Program for OTC products to be fully implemented nationwide in September
The Drug Utilization Review (DUR) system for over-the-counter drugs will be fully implemented throughout the country from September to promote patient safety by an increased review and awareness of OTC medicines, acco...
Daewoong and AstraZeneca Korea to co-market Symbicort in Korea
Daewoong Pharmaceutical and AstraZeneca Korea (AZK) Monday announced that the two companies have signed an agreement to co-market Symbicort (budesonide/formoterol) in Korea, in addition to Nexium.
Launched in 2001,...
Dong-A to develop molecular diagnostic technology
Dong-A Pharmaceutical and the US-based Nanogea announced on July 22 that both companies have signed a letter of intent for the co-development and commercialization of new molecular diagnostics, using the latter’s prop...
KPMA proposes meeting with President
The Korea Pharmaceutical Manufacturers Association (KPMA) Friday proposed a meeting with President Lee Myung-bak.
“Having talks with President Lee is quite meaningful as we want to discuss the unclear growth of the...
New oral antiplatelet agent ticagrelor approved in Korea
The Korea Food and Drug Administration said Thursday that it has approved AstraZeneca’s Brilinta (ticagrelor) to reduce the rate of heart attack (myocardial infarction; MI) and cardiovascular (CV) death in adult patie...
